L04AC — Interleikīnu inhibitori
Interleikīnu inhibitori (Interleukin inhibitors)
| Aktīvā viela | Zāļu nosaukumi |
|---|---|
| Anakinrum | Kineret |
| Basiliximabum | Simulect |
| Bimekizumabum | Bimzelx |
| Brodalumabum | Kyntheum |
| Canakinumabum | Ilaris |
| Guselkumabum | Tremfya |
| Ixekizumabum | Taltz |
| Mirikizumabum | Omvoh |
| Risankizumabum | Skyrizi |
| Sarilumabum | Kevzara |
| Satralizumabum | Enspryng |
| Secukinumabum | Cosentyx |
| Siltuximabum | Sylvant |
| Spesolimabum | Spevigo |
| Tildrakizumabum | Ilumetri |
| Tocilizumabum | Avtozma, RoActemra, Tocilizumab STADA, Tuyory, Tyenne |
| Ustekinumabum | Fymskina, Imuldosa, Otulfi, Pyzchiva, Qoyvolma, Stelara |
Kompensējamās zāles
Šajā grupā 6 ATĶ kodi ir NVD kompensējamo zāļu sarakstā. Saraksts spēkā no 01.07.2026.
NVD6izraksta speciālists
| ATĶ | Aktīvā viela | Kompensācija | Izrakstīšana |
|---|---|---|---|
| L04AC03 | Anakinrum | 100% | NVD |
| L04AC05 | Ustekinumabum | 100% | NVD |
| L04AC07 | Tocilizumabum | 100% | NVD |
| L04AC10 | Secukinumabum, Secukinumabum 300mg deva, Secukinumabum 150mg deva | 100% | NVD |
| L04AC16 | Guselkumabum | 100% | NVD |
| L04AC18 | Risankizumabum 360mg un 600mg deva, Risankizumabum 150mg deva | 100% | NVD |
Apakšgrupas
L04AC02 - Baziliksimabs
L04AC03 - Anakinra
L04AC05 - Ustekinumabs
L04AC07 - Tocilizumabs
L04AC08 - Kanakinumabs
L04AC10 - Sekukinumabs
L04AC11 - Siltuksimabs
L04AC12 - Brodalumabs
L04AC13 - Iksekizumabs
L04AC14 - Sarilumabs
L04AC16 - Guselkumabs
L04AC17 - Tildrakizumabs
L04AC18 - Risankizumabs
L04AC19 - Satralizumabs
L04AC21 - Bimekizumabs
L04AC22 - Spesolimabs
L04AC24 - Mirikizumabs
Avots: Zāļu valsts aģentūras Zāļu reģistrs · ATĶ klasifikators: data.gov.lv · kompensācija: NVD kompensējamo zāļu saraksts